“Scientists discover Easter Island ‘fountain of youth’ drug that can extend life by 10 years,” a recent newspaper headline read.
“Coffee may ‘reverse’ Alzheimer’s,” another said.
Amazing and shocking stuff, but there’s a caveat — the research that fueled the stories was done on mice.
Mus musculus is the creature most experimented on in the history of humanity and you can bet that any modern pharmaceutical medical treatment or basic understanding of genetics has involved working on a mouse at some point. Approximately 85 percent of all animals used in experiments are rodents and the vast majority of those are mice.
And for good reason.
“Mice are used because they’re the smallest and one of the easiest mammals to study in a laboratory setting — they breed quickly and are good enough for many types of study,” says Simon Festing, chief executive of the UK pro-research charity Understanding Animal Research.
“While there are differences, we know that the main biological body systems work in the same way in all mammals. The reproductive, endocrine and cardiovascular and the central nervous systems all have a very similar structure and function,” he says. “Mice share over 90 percent of their genes with humans.”
However, using a mouse can never tell scientists everything they need to know. A result on a mouse is an interesting lead but only replication in a higher animal, such as a dog or a monkey, pushes it closer to becoming a reality for people. In the case of the Easter Island elixir (a drug called rapamycin), reports suggested that the anti-aging pill made from chemicals found on the islands had extended the life of mice by up to 38 percent — but the researchers warned that humans should not think about using the drug to extend life because it suppresses immunity.
And the Alzheimer’s study, published in the Journal of Alzheimer’s Disease, showed that caffeine could slow down the build-up of protein plaques, which are the signature of the disease and cause the damage to the brain. The mice were given the equivalent of five cups of coffee per day, containing around 500mg of caffeine, and showed almost a 50 percent reduction in the levels of the protein plaques in their brains after two months. But the scientists cautioned that, though caffeine was a relatively safe drug, there was no indication yet about the amounts of the chemical that would act successfully against Alzheimer’s in humans. And pregnant women and people with high blood pressure should certainly avoid upping their caffeine intake.
There are several reasons why results on mice have problems translating directly to humans. When researching whether a drug works, doses on mice are sometimes much higher than anything that a doctor could safely use on a patient, even allowing for adjustments of metabolic rate and size. “Because your primary concern in the animal experiments is to demonstrate an effective treatment, you will dose higher than you would in a human,” says Dominic Wells, head of the department of cellular and molecular neuroscience at Imperial College London.
“So if you hear a story that a mouse has been cured of this or that, you need to take that with a big pinch of salt because we would almost certainly not be allowed to take the same sort of dose rate straight into a human. We’d need to make a significant reduction to test for safety before we could consider upping the dose,” he says.
Trials using animals tend to focus on a single question — efficacy or toxicity, for example. But to make something suitable for humans requires the management of side-effects, and this might take years to tackle.
In 2006, Daniel Hackam of the University of Toronto looked at how many animal-based experiments had been later verified by successful human trials. Out of 76 studies published between 1980 and 2000, 28 were successfully replicated in human randomized trials, 14 were contradicted in trials and 34 remained untested.
In a letter published in the Journal of the American Medical Association, Hackam wrote: “Patients and physicians should remain cautious about extrapolating the findings of prominent animal research to the care of human disease ... poor replication of even high-quality animal studies should be expected by those who conduct clinical research.”
There are also physiological limitations.
“We can genetically modify, by a single intramuscular injection, a whole muscle in a mouse,” Wells says. “If we try to do that in a person it just doesn’t work because the spread of the agent we inject is maybe 4 to 5 millimeters — the size of a mouse muscle.”
And in other areas, mice are not sophisticated enough to model humans.
Neurologically, “mice are wired in a different way,” Wells says. “If I showed you a blind mouse and a mouse with perfect eyesight in a cage, you wouldn’t be able to tell the difference because mice rely a lot on smell and touch.”
None of this should put a negative spin, however, on the importance of mice in research. So far, 26 Nobel prizes have gone to discoveries where research on mice has been key, including work on vitamins, the discovery of penicillin, the development of numerous vaccines and understanding the role of viruses.
From the Iran war and nuclear weapons to tariffs and artificial intelligence, the agenda for this week’s Beijing summit between US President Donald Trump and Chinese President Xi Jinping (習近平) is packed. Xi would almost certainly bring up Taiwan, if only to demonstrate his inflexibility on the matter. However, no one needs to meet with Xi face-to-face to understand his stance. A visit to the National Museum of China in Beijing — in particular, the “Road to Rejuvenation” exhibition, which chronicles the rise and rule of the Chinese Communist Party — might be even more revealing. Xi took the members
The Chinese Nationalist Party (KMT) and the Taiwan People’s Party (TPP) on Friday used their legislative majority to push their version of a special defense budget bill to fund the purchase of US military equipment, with the combined spending capped at NT$780 billion (US$24.78 billion). The bill, which fell short of the Executive Yuan’s NT$1.25 trillion request, was passed by a 59-0 margin with 48 abstentions in the 113-seat legislature. KMT Chairwoman Cheng Li-wun (鄭麗文), who reportedly met with TPP Chairman Huang Kuo-chang (黃國昌) for a private meeting before holding a joint post-vote news conference, was said to have mobilized her
The inter-Korean relationship, long defined by national division, offers the clearest mirror within East Asia for cross-strait relations. Yet even there, reunification language is breaking down. The South Korean government disclosed on Wednesday last week that North Korea’s constitutional revision in March had deleted references to reunification and added a territorial clause defining its border with South Korea. South Korea is also seriously debating whether national reunification with North Korea is still necessary. On April 27, South Korean President Lee Jae-myung marked the eighth anniversary of the Panmunjom Declaration, the 2018 inter-Korean agreement in which the two Koreas pledged to
I wrote this before US President Donald Trump embarked on his uneventful state visit to China on Thursday. So, I shall confine my observations to the joint US-Philippine military exercise of April 20 through May 8, known collectively as “Balikatan 2026.” This year’s Balikatan was notable for its “firsts.” First, it was conducted primarily with Taiwan in mind, not the Philippines or even the South China Sea. It also showed that in the Pacific, America’s alliance network is still robust. Allies are enthusiastic about America’s renewed leadership in the region. Nine decades ago, in 1936, America had neither military strength
RSS